BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Catalog Number D139505 |
Device Problem
Coagulation in Device or Device Ingredient (1096)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/06/2024 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation ablation procedure with a qdot micro¿ catheter and after the catheter had been used for some time during the procedure, the physician went to flush the catheter and char got stuck in the syringe.The physician ended up removing the catheter from the body and did not replace the catheter since they were at the end of the procedure.There were no error messages on the equipment.The patient was properly anticoagulated.According to the physician, the amount of char did not present a patient risk.No patient consequences were reported.
|
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
On 19-feb-2024, bwi received additional information indicating that the patient had no suffered from any neurological symptoms post procedure.On 14-mar-2024, the bwi product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
On 18-mar-2024, the product investigation was completed.It was reported that a patient underwent an atrial fibrillation ablation procedure with a qdot micro¿ catheter and after the catheter had been used for some time during the procedure, the physician went to flush the catheter and char got stuck in the syringe.The physician ended up removing the catheter from the body and did not replace the catheter since they were at the end of the procedure.There were no error messages on the equipment.The patient was properly anticoagulated.According to the physician, the amount of char did not present a patient risk.No patient consequences were reported.Device evaluation details: the device was returned to biosense webster (bwi) for evaluation.A visual inspection, temperature, impedance and patency test of the returned device were performed in accordance with bwi procedures.Visual analysis revealed no damage or anomalies on the device.No char, thrombus or clot residues were observed during the inspection.The temperature and impedance test was performed, and no issues were observed.A patency test was performed, and the device was flushing correctly.No issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device number lot 31210183l and no internal actions related to the complaint was found during the review.The issue reported by the customer could not be replicated during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.Monitoring the temperature from the electrode during the application of rf (radiofrequency) current ensures that the irrigation flow rate is being maintained.Using tip temperature to guide ablation could result in deeper lesions and increased risk for collateral damage.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|
|